BHlthSci, GradDipHlthSci, MBBS (Hons), FRANZCR
Radiation Oncologist
Dr Paul Conway provides compassionate, patient-centred cancer care. He combines advanced techniques and technology to offer the highest quality of treatment available — a level of care he would trust for his own family.
Quick Scroll
Dr Paul Conway provides compassionate, patient-centred cancer care. He combines advanced techniques and technology to offer the highest quality of treatment available— a level of care he would trust for his own family.
Paul completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) with First Class Honours at the University of Queensland in 2013. He undertook specialty training at the Royal Brisbane and Women’s Hospital, Alfred Health, and Peter MacCallum Cancer Centre, becoming a Fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2021. He further refined his skills during a two-year fellowship under Dr Pat Bowden, focusing on advanced techniques in managing urologic and metastatic diseases, including over 250 supervised courses of stereotactic radiotherapy for oligometastatic disease. Dr Conway now collaborates with Dr Pat Bowden, leveraging their combined expertise to benefit patients.
His commitment to advanced cancer treatments has taken him to Japan, where he gained valuable insights into Proton Beam Therapy at the National Cancer Centre Hospital East and Tsukuba Proton Beam Therapy Centre. Additionally, he has completed training and credentialing in the CyberKnife system, the most advanced stereotactic radiation delivery system available. Dr Conway has a keen interest in incorporating advanced technologies in providing care for his patients. He is currently incorporating next-generation dynamic imaging with the latest Quadra PET/CT technology for more precise radiotherapy planning and treatment.
Dr Conway’s current research interests centre on advancements in imaging and treatment technologies. His research includes dynamic PET imaging and novel tracer technology to improve disease detection and characterisation for precise treatment planning. He is actively involved in the follow-up of the TRANSFORM trial, led by Dr Pat Bowden, which is the largest study of its kind in the world investigating the use of stereotactic radiotherapy for treating oligometastatic prostate cancer.
He specialises in treating a diverse range of malignancies, with particular expertise in urologic cancers (including prostate cancer), gastrointestinal cancers, breast cancer, lung and central nervous system (CNS) cancers, and oligometastatic disease. Dr Conway was elected as the Radiation Oncology representative on the Medical Advisory Committee for John Fawkner Hospital in Victoria.
Dr Conway provides stereotactic radiotherapy treatment at a number of cancer centres throughout Melbourne, and in Canberra, with accommodation made available for those travelling from interstate or abroad for treatment.